Clinical trial Recruiting at 1 site Observational Ages 18 and up

Registry of patients treated with transcatheter aortic valve implantation in Leipzig

Official title: An Observational Follow-up Assessment of Transcatheter Aortic Valve Implantation in Leipzig

Run by Helios Health Institute GmbH · NCT05015452 · Data updated 2026-11-12

This study collects information from patients who have received a new heart valve through a minimally invasive procedure in Leipzig to see how well the treatment works over time.

More Aortic Valve Stenosis trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment20000 (estimated)
SponsorHelios Health Institute GmbH
Academic / other
Locations1 site (Leipzig)
StatusRecruiting
StartedMarch 1, 2020
Main results expectedDecember 31, 2030
Study endsDecember 31, 2030
Registry record updatedOctober 9, 2024
Trial IDNCT05015452 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this registry are all patients who are treated with TAVI at the Heart Center in Leipzig.

Probably not a fit

Patients who do not undergo TAVI or are treated at other centers may not benefit from this registry.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry collects data on all patients who undergo transcatheter aortic valve implantation (TAVI) at the Heart Center in Leipzig, Germany. It includes routine clinical assessments and echocardiographic follow-ups to monitor patient outcomes and valve durability over a long-term period of up to 10 years. The aim is to gather comprehensive data that can help improve treatment protocols and patient care for those with aortic valve stenosis.

Why it matters

Potential benefit: If successful, this registry could enhance understanding of TAVI outcomes and improve treatment strategies for patients with aortic valve stenosis.

How similar studies have gone: Other registries and studies on TAVI have shown success in improving patient outcomes and understanding valve durability, indicating that this approach is supported by prior evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All patients treated with TAVI

Exclusion Criteria:

* None

Where it's running

  • Herzzentrum Leipzig
    Leipzig, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.